UPDATE: Needham On Celcuity Buy Initiation Earlier: Firm Highlights Development Of CELsignia Next-Gen Cancer Diagnostic Discovery Platform; Uses Whole Cells To Query Entire Pathways To Give A More Comprehensive Picture Of Cancer Cell Dysfunction